Assessment of Donor Derived Cell Free DNA and Utility in Lung Transplantation

Stopped early · Not applicable

Conditions studied: Lung Transplant Failure and Rejection

In brief

The use of Allosure to identify and quantify circulating donor-derived cell-free DNA to quantitate allograft injury in the early post-transplant period and determine its relationship to allograft failure.

Key facts

Study ID

NCT04318587

Run by

Pablo Sanchez

People needed

40

Starts

2020-06-29

Expected to finish

2023-12-30

Last updated by the study team

2024-03-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant is willing and able to give informed consent for participation in the study.
• Male or Female, aged 18 years or above.
• Denovo lung transplant recipient
• Ability to understand written and spoken English

You may not qualify if…

• Previous transplant or multi-organ transplant
• Unable to have blood draw for medical reason

Where it is running

• UPMC Presbyterian — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.